SAN RAMON, Calif., Nov. 18, 2019 /PRNewswire/ -- CooperVision announced today it has received U.S. Food and Drug Administration (FDA) approval of its innovative MiSight® 1 day contact lens1. The ...

ROCHESTER, N.Y., Feb. 10, 2026 /PRNewswire/ -- CooperVision today announced immediate availability of its MiSight ® 1 day * myopia control contact lens in Japan, where as many as 77% of elementary ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

CooperVision announced it has received U.S. Food and Drug Administration (FDA) approval on Nov. 15, 2019 of its innovative MiSight ® 1 day contact lens. The cornerstone of a comprehensive myopia ...

New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl Technology *1 to Slow the Worsening of Myopia in Children †2,3 FAREHAM, England, Jan. 6, 2026 /PRNewswire/ -- ...

The expansions underscore the company's commitment to making evidence-based myopia management interventions accessible to eye care professionals (ECPs) and children worldwide. "Myopia is a pressing ...

"This is another significant step forward in our mission to take on myopia at a global scale," said Debbie Olive, Chief Commercial Officer, CooperVision. "For children and families affected, myopia ...

MiSight ® 1 day will launch in the U.S. as part of a CooperVision myopia management initiative beginning in March 2020. The lens is already being successfully worn by thousands of myopic children in ...